Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Invivyd, Inc. - Common Stock (NQ: IVVD )

1.310 -0.120 (-8.39%)
Streaming Delayed Price Updated: 3:22 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 378,625
Open 1.380
Bid (Size) 1.300 (3)
Ask (Size) 1.320 (3)
Prev. Close 1.430
Today's Range 1.030 - 1.480
52wk Range 1.380 - 4.890
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
Via Benzinga
Invivyd Reports Full Year 2022 Financial Results and Business Highlights
From Invivyd
Via Globe NewsWire

Performance

YTD
-15.48%
-15.48%
1 Month
-31.05%
-31.05%
3 Month
-20.61%
-20.61%
6 Month
-59.94%
-59.94%
1 Year
-72.88%
-72.88%

More News

Read More
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Invivyd, Honda, Allianz, and Block and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Invivyd Earnings Preview
Via Benzinga
Earnings Scheduled For March 23, 2023
Via Benzinga
Invivyd Publishes Model for Evaluating Biomarker Correlates of Protection for Monoclonal Antibodies Against Symptomatic COVID-19
From Invivyd
Via Globe NewsWire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important April 3 Deadline in Securities Class Action - IVVD, ADGI
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
INVIVYD, INC. (NASDAQ: IVVD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD)
From Bernstein Liebhard LLP
Via Globe NewsWire
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
From The Rosen Law Firm PA
Via Globe NewsWire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RYVYL, Invivyd, Honda, Allianz and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Invivyd to Host Conference Call Discussing Full Year 2022 Financial Results and Business Highlights
From Invivyd
Via Globe NewsWire
NASDAQ:IVVD Investor Notice: Deadline on April 3, 2023 in Lawsuit Against Invivyd, Inc. Coming Up
Via SBWire
INVIVYD, INC. (NASDAQ: IVVD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD)
From Bernstein Liebhard LLP
Via Globe NewsWire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National Vision, RYVYL, Invivyd, and Honda and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Invivyd, Inc. (IVVD) Investors and Encourages Investors to Contact the Firm Before April 3, 2023
From Kirby McInerney LLP
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National Vision, RYVYL, Invivyd, and Honda and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
From The Rosen Law Firm PA
Via Globe NewsWire
Invivyd Optimizes Development Efficiency with Election of VYD222 for Near-Term Clinical Advancement to Address Urgent Unmet Need for COVID-19 Monoclonal Antibodies
From Invivyd
Via Globe NewsWire
INVIVYD, INC. (NASDAQ: IVVD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD)
From Bernstein Liebhard LLP
Via Globe NewsWire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RYVYL, Invivyd, Honda, Allianz and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
IVVD LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Invivyd to Participate at Cowen’s 43rd Annual Healthcare Conference
From Invivyd
Via Globe NewsWire
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.